1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Biosimilar Testing Service Revenue 1.4 Market Analysis by Type 1.4.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Pharmacokinetic Assay 1.4.3 Tiered Immunogenicity Testing 1.4.4 Others 1.5 Market by Application 1.5.1 Global Biosimilar Testing Service Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Pharmaceutical Companies 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Biosimilar Testing Service Industry Impact 1.6.1 How the Covid-19 is Affecting the Biosimilar Testing Service Industry 1.6.1.1 Biosimilar Testing Service Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Biosimilar Testing Service Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Biosimilar Testing Service Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Biosimilar Testing Service Market Perspective (2015-2026) 2.2 Biosimilar Testing Service Growth Trends by Regions 2.2.1 Biosimilar Testing Service Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Biosimilar Testing Service Historic Market Share by Regions (2015-2020) 2.2.3 Biosimilar Testing Service Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Biosimilar Testing Service Market Growth Strategy 2.3.6 Primary Interviews with Key Biosimilar Testing Service Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Biosimilar Testing Service Players by Market Size 3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2015-2020) 3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2015-2020) 3.1.3 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Biosimilar Testing Service Market Concentration Ratio 3.2.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2019 3.3 Biosimilar Testing Service Key Players Head office and Area Served 3.4 Key Players Biosimilar Testing Service Product Solution and Service 3.5 Date of Enter into Biosimilar Testing Service Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Biosimilar Testing Service Historic Market Size by Type (2015-2020) 4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2021-2026) 5 Biosimilar Testing Service Breakdown Data by Application (2015-2026) 5.1 Global Biosimilar Testing Service Market Size by Application (2015-2020) 5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Biosimilar Testing Service Market Size (2015-2020) 6.2 Biosimilar Testing Service Key Players in North America (2019-2020) 6.3 North America Biosimilar Testing Service Market Size by Type (2015-2020) 6.4 North America Biosimilar Testing Service Market Size by Application (2015-2020) 7 Europe 7.1 Europe Biosimilar Testing Service Market Size (2015-2020) 7.2 Biosimilar Testing Service Key Players in Europe (2019-2020) 7.3 Europe Biosimilar Testing Service Market Size by Type (2015-2020) 7.4 Europe Biosimilar Testing Service Market Size by Application (2015-2020) 8 China 8.1 China Biosimilar Testing Service Market Size (2015-2020) 8.2 Biosimilar Testing Service Key Players in China (2019-2020) 8.3 China Biosimilar Testing Service Market Size by Type (2015-2020) 8.4 China Biosimilar Testing Service Market Size by Application (2015-2020) 9 Japan 9.1 Japan Biosimilar Testing Service Market Size (2015-2020) 9.2 Biosimilar Testing Service Key Players in Japan (2019-2020) 9.3 Japan Biosimilar Testing Service Market Size by Type (2015-2020) 9.4 Japan Biosimilar Testing Service Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Biosimilar Testing Service Market Size (2015-2020) 10.2 Biosimilar Testing Service Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Biosimilar Testing Service Market Size by Type (2015-2020) 10.4 Southeast Asia Biosimilar Testing Service Market Size by Application (2015-2020) 11 India 11.1 India Biosimilar Testing Service Market Size (2015-2020) 11.2 Biosimilar Testing Service Key Players in India (2019-2020) 11.3 India Biosimilar Testing Service Market Size by Type (2015-2020) 11.4 India Biosimilar Testing Service Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Biosimilar Testing Service Market Size (2015-2020) 12.2 Biosimilar Testing Service Key Players in Central & South America (2019-2020) 12.3 Central & South America Biosimilar Testing Service Market Size by Type (2015-2020) 12.4 Central & South America Biosimilar Testing Service Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Charles River Laboratories International 13.1.1 Charles River Laboratories International Company Details 13.1.2 Charles River Laboratories International Business Overview and Its Total Revenue 13.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction 13.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2015-2020)) 13.1.5 Charles River Laboratories International Recent Development 13.2 Merck 13.2.1 Merck Company Details 13.2.2 Merck Business Overview and Its Total Revenue 13.2.3 Merck Biosimilar Testing Service Introduction 13.2.4 Merck Revenue in Biosimilar Testing Service Business (2015-2020) 13.2.5 Merck Recent Development 13.3 PPD 13.3.1 PPD Company Details 13.3.2 PPD Business Overview and Its Total Revenue 13.3.3 PPD Biosimilar Testing Service Introduction 13.3.4 PPD Revenue in Biosimilar Testing Service Business (2015-2020) 13.3.5 PPD Recent Development 13.4 LAB Holdings 13.4.1 LAB Holdings Company Details 13.4.2 LAB Holdings Business Overview and Its Total Revenue 13.4.3 LAB Holdings Biosimilar Testing Service Introduction 13.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2015-2020) 13.4.5 LAB Holdings Recent Development 13.5 Eurofins Scientific 13.5.1 Eurofins Scientific Company Details 13.5.2 Eurofins Scientific Business Overview and Its Total Revenue 13.5.3 Eurofins Scientific Biosimilar Testing Service Introduction 13.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2015-2020) 13.5.5 Eurofins Scientific Recent Development 13.6 Intertek 13.6.1 Intertek Company Details 13.6.2 Intertek Business Overview and Its Total Revenue 13.6.3 Intertek Biosimilar Testing Service Introduction 13.6.4 Intertek Revenue in Biosimilar Testing Service Business (2015-2020) 13.6.5 Intertek Recent Development 13.7 SGS 13.7.1 SGS Company Details 13.7.2 SGS Business Overview and Its Total Revenue 13.7.3 SGS Biosimilar Testing Service Introduction 13.7.4 SGS Revenue in Biosimilar Testing Service Business (2015-2020) 13.7.5 SGS Recent Development 13.8 Profacgen 13.8.1 Profacgen Company Details 13.8.2 Profacgen Business Overview and Its Total Revenue 13.8.3 Profacgen Biosimilar Testing Service Introduction 13.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2015-2020) 13.8.5 Profacgen Recent Development 13.9 Antibody Analytics 13.9.1 Antibody Analytics Company Details 13.9.2 Antibody Analytics Business Overview and Its Total Revenue 13.9.3 Antibody Analytics Biosimilar Testing Service Introduction 13.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2015-2020) 13.9.5 Antibody Analytics Recent Development 13.10 Kymos Pharma Services 13.10.1 Kymos Pharma Services Company Details 13.10.2 Kymos Pharma Services Business Overview and Its Total Revenue 13.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction 13.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2015-2020) 13.10.5 Kymos Pharma Services Recent Development 13.11 Medicilon 10.11.1 Medicilon Company Details 10.11.2 Medicilon Business Overview and Its Total Revenue 10.11.3 Medicilon Biosimilar Testing Service Introduction 10.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2015-2020) 10.11.5 Medicilon Recent Development 13.12 Pacific BioLabs 10.12.1 Pacific BioLabs Company Details 10.12.2 Pacific BioLabs Business Overview and Its Total Revenue 10.12.3 Pacific BioLabs Biosimilar Testing Service Introduction 10.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2015-2020) 10.12.5 Pacific BioLabs Recent Development 13.13 Sartorius 10.13.1 Sartorius Company Details 10.13.2 Sartorius Business Overview and Its Total Revenue 10.13.3 Sartorius Biosimilar Testing Service Introduction 10.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2015-2020) 10.13.5 Sartorius Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Biosimilar Testing Service Key Market Segments Table 2. Key Players Covered: Ranking by Biosimilar Testing Service Revenue Table 3. Ranking of Global Top Biosimilar Testing Service Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Biosimilar Testing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Pharmacokinetic Assay Table 6. Key Players of Tiered Immunogenicity Testing Table 7. Key Players of Others Table 8. COVID-19 Impact Global Market: (Four Biosimilar Testing Service Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Biosimilar Testing Service Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Biosimilar Testing Service Players to Combat Covid-19 Impact Table 13. Global Biosimilar Testing Service Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Biosimilar Testing Service Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Biosimilar Testing Service Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Biosimilar Testing Service Market Share by Regions (2015-2020) Table 17. Global Biosimilar Testing Service Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Biosimilar Testing Service Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Biosimilar Testing Service Market Growth Strategy Table 23. Main Points Interviewed from Key Biosimilar Testing Service Players Table 24. Global Biosimilar Testing Service Revenue by Players (2015-2020) (Million US$) Table 25. Global Biosimilar Testing Service Market Share by Players (2015-2020) Table 26. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing Service as of 2019) Table 27. Global Biosimilar Testing Service by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Biosimilar Testing Service Product Solution and Service Table 30. Date of Enter into Biosimilar Testing Service Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 33. Global Biosimilar Testing Service Market Size Share by Type (2015-2020) Table 34. Global Biosimilar Testing Service Revenue Market Share by Type (2021-2026) Table 35. Global Biosimilar Testing Service Market Size Share by Application (2015-2020) Table 36. Global Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 37. Global Biosimilar Testing Service Market Size Share by Application (2021-2026) Table 38. North America Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 39. North America Key Players Biosimilar Testing Service Market Share (2019-2020) Table 40. North America Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 41. North America Biosimilar Testing Service Market Share by Type (2015-2020) Table 42. North America Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 43. North America Biosimilar Testing Service Market Share by Application (2015-2020) Table 44. Europe Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Biosimilar Testing Service Market Share (2019-2020) Table 46. Europe Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 47. Europe Biosimilar Testing Service Market Share by Type (2015-2020) Table 48. Europe Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 49. Europe Biosimilar Testing Service Market Share by Application (2015-2020) Table 50. China Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 51. China Key Players Biosimilar Testing Service Market Share (2019-2020) Table 52. China Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 53. China Biosimilar Testing Service Market Share by Type (2015-2020) Table 54. China Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 55. China Biosimilar Testing Service Market Share by Application (2015-2020) Table 56. Japan Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 57. Japan Key Players Biosimilar Testing Service Market Share (2019-2020) Table 58. Japan Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 59. Japan Biosimilar Testing Service Market Share by Type (2015-2020) Table 60. Japan Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 61. Japan Biosimilar Testing Service Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players Biosimilar Testing Service Market Share (2019-2020) Table 64. Southeast Asia Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia Biosimilar Testing Service Market Share by Type (2015-2020) Table 66. Southeast Asia Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia Biosimilar Testing Service Market Share by Application (2015-2020) Table 68. India Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 69. India Key Players Biosimilar Testing Service Market Share (2019-2020) Table 70. India Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 71. India Biosimilar Testing Service Market Share by Type (2015-2020) Table 72. India Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 73. India Biosimilar Testing Service Market Share by Application (2015-2020) Table 74. Central & South America Key Players Biosimilar Testing Service Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players Biosimilar Testing Service Market Share (2019-2020) Table 76. Central & South America Biosimilar Testing Service Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America Biosimilar Testing Service Market Share by Type (2015-2020) Table 78. Central & South America Biosimilar Testing Service Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America Biosimilar Testing Service Market Share by Application (2015-2020) Table 80. Charles River Laboratories International Company Details Table 81. Charles River Laboratories International Business Overview Table 82. Charles River Laboratories International Product Table 83. Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 84. Charles River Laboratories International Recent Development Table 85. Merck Company Details Table 86. Merck Business Overview Table 87. Merck Product Table 88. Merck Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 89. Merck Recent Development Table 90. PPD Company Details Table 91. PPD Business Overview Table 92. PPD Product Table 93. PPD Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 94. PPD Recent Development Table 95. LAB Holdings Company Details Table 96. LAB Holdings Business Overview Table 97. LAB Holdings Product Table 98. LAB Holdings Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 99. LAB Holdings Recent Development Table 100. Eurofins Scientific Company Details Table 101. Eurofins Scientific Business Overview Table 102. Eurofins Scientific Product Table 103. Eurofins Scientific Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 104. Eurofins Scientific Recent Development Table 105. Intertek Company Details Table 106. Intertek Business Overview Table 107. Intertek Product Table 108. Intertek Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 109. Intertek Recent Development Table 110. SGS Company Details Table 111. SGS Business Overview Table 112. SGS Product Table 113. SGS Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 114. SGS Recent Development Table 115. Profacgen Business Overview Table 116. Profacgen Product Table 117. Profacgen Company Details Table 118. Profacgen Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 119. Profacgen Recent Development Table 120. Antibody Analytics Company Details Table 121. Antibody Analytics Business Overview Table 122. Antibody Analytics Product Table 123. Antibody Analytics Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 124. Antibody Analytics Recent Development Table 125. Kymos Pharma Services Company Details Table 126. Kymos Pharma Services Business Overview Table 127. Kymos Pharma Services Product Table 128. Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 129. Kymos Pharma Services Recent Development Table 130. Medicilon Company Details Table 131. Medicilon Business Overview Table 132. Medicilon Product Table 133. Medicilon Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 134. Medicilon Recent Development Table 135. Pacific BioLabs Company Details Table 136. Pacific BioLabs Business Overview Table 137. Pacific BioLabs Product Table 138. Pacific BioLabs Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 139. Pacific BioLabs Recent Development Table 140. Sartorius Company Details Table 141. Sartorius Business Overview Table 142. Sartorius Product Table 143. Sartorius Revenue in Biosimilar Testing Service Business (2015-2020) (Million US$) Table 144. Sartorius Recent Development Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Biosimilar Testing Service Market Share by Type: 2020 VS 2026 Figure 2. Pharmacokinetic Assay Features Figure 3. Tiered Immunogenicity Testing Features Figure 4. Others Features Figure 5. Global Biosimilar Testing Service Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Pharmaceutical Companies Case Studies Figure 8. Others Case Studies Figure 9. Biosimilar Testing Service Report Years Considered Figure 10. Global Biosimilar Testing Service Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Biosimilar Testing Service Market Share by Regions: 2020 VS 2026 Figure 12. Global Biosimilar Testing Service Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Biosimilar Testing Service Market Share by Players in 2019 Figure 15. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing Service as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Testing Service Revenue in 2019 Figure 17. North America Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Biosimilar Testing Service Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Charles River Laboratories International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Charles River Laboratories International Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 26. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Merck Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 28. PPD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. PPD Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 30. LAB Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. LAB Holdings Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 32. Eurofins Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 34. Intertek Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Intertek Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 36. SGS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. SGS Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 38. Profacgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Profacgen Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 40. Antibody Analytics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Antibody Analytics Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 42. Kymos Pharma Services Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Kymos Pharma Services Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 44. Medicilon Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Medicilon Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 46. Pacific BioLabs Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Pacific BioLabs Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 48. Sartorius Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Sartorius Revenue Growth Rate in Biosimilar Testing Service Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Charles River Laboratories International Merck PPD LAB Holdings Eurofins Scientific Intertek SGS Profacgen Antibody Analytics Kymos Pharma Services Medicilon Pacific BioLabs Sartorius